Promoting early HIV diagnosis and entry into care

AIDS

Volumn 13, Issue 17, 1999, Pages 2317-2330

  Valdiserri, Ronald O ^a,b   Holtgrave, David R ^a   West, Gary R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DIAGNOSIS; EDITORIAL; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; UNITED STATES; VIRUS DIAGNOSIS;

AGE FACTORS; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; ETHNIC GROUPS; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; MALE; MARKETING OF HEALTH SERVICES; RISK-TAKING; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES;

EID: 0032786018     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199912030-00003     Document Type: Editorial

References (155)

1. 1. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998, 280:78-86.
2. 2. Wortley PM, Chu SY, Diaz, T, et al. HIV testing patterns: where, why and when were persons with AIDS tested for HIV? AIDS 1995, 9:487-492.
3. 3. Hamers FF, Delmas MC, Alix J. Unawareness of HIV seropositivity before AIDS diagnosis in Europe. 12th World AIDS Conference. Geneva, July 1998 [abstract 43105].
4. 4. Wenger NS, Kusseling FS, Beck K, Shapiro MF. When patients first suspect and find out they are infected with the human immunodeficiency virus: implications for prevention. AIDS Care 1994, 6:399-405.
5. 5. Siegel K, Raveis VH, Gorey E. Barriers and pathways to testing among HIV-infected women. AIDS Educ Prev 1998, 10:114-127.
6. 6. Siegel K, Karus D, Raveis VH. Testing and treatment behavior of HIV-infected women: white, African-American, Puerto Rican comparisons. AIDS Care 1997, 9:297-309.
7. 7. Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, Levenson SM, Hingson R. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998, 158:734-740.
8. 8. Levy JA. Caution: should we be treating HIV infection early? Lancet 1998, 352:982-983.
9. 9. Francis DP, Anderson RE, Gorman ME, Fenstersheib M, Padian NS, Kizer KW, Conant MA. Targeting AIDS prevention and treatment toward HIV-1 infected persons: the concept of early intervention. JAMA 1989, 262:2572-2576.
10. 10. Denning P, Nakashima A, Wortley C, and the SHAS Project Group. High-risk sexual behaviors among HIV-infected adolescents and young adults. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January 1999 [abstract 473].
11. 11. Alwano-Edyegu MG, Marum E. Knowledge is power: voluntary HIV counseling and testing in Uganda. Geneva: UNAIDS; 1999.
12. 12. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739.
13. 13. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
14. 14. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997, 71:6271-6275.
15. 15. Valdiserri RO. HIV counseling and testing: its evolving role in HIV prevention. AIDS Educ Prev 1997, 9 (Suppl. B):2-13.
16. 16. Kassler WJ. Advances in HIV testing technology and their potential impact on prevention. AIDS Educ Prev 1997, 9 (Suppl. B):27-40.
17. 17. Schoenborn CA, Marsh SL, Hardy A. AIDS knowledge and attitudes for 1992: data from the National Health Interview Survey. Advance data from vital and health statistics, no. 243. Hyattsville, Maryland: National Center for Health Statistics; 1994.
18. 18. Valdiserri RO, Holtgrave DR, Brackbill R. American adults' knowledge of HIV testing availability. Am J Public Health 1993, 83:525-528.
19. 19. Weber JT, Frey RL, Horsley R, Gwinn ML. Publicly funded HIV counseling and testing in the United States, 1992-1995. AIDS Educ Prev 1997, 9 (Suppl. B):79-91.
20. 20. Centers for Disease Control. HIV counseling and testing services from public and private providers - United States, 1990. MMWR 1992, 41:743-752.
21. 21. Centers for Disease Control. Testing for HIV in the public and private sectors - Oregon, 1988-1991. MMWR 1992, 41:581-584.
22. 22. Valdiserri RO, Weber JT, Frey R. Trends in HIV seropositivity in publicly funded HIV counseling and testing programs: implications for prevention policy. Am J Prev Med 1998, 14:31-42.
23. 23. Centers for Disease Control. HIV counseling and testing in publicly funded sites: 1996 Annual Review. Atlanta, GA; 1998.
24. 24. Berrios DC, Hearst N, Coates TJ, et al. HIV antibody testing among those at risk for infection: the National AIDS Behavioral Surveys. JAMA 1993, 270:1576- 1580.
25. 25. Holtzman D, Bland SD, McQueen DV. Trends in HIV testing among US adults, 1993-1996. 12th World AIDS Conference. Geneva, July 1998 [abstract 43127].
26. 26. Holtzman D, Bland SD, Nakashima A. HIV testing rates and trends among US adults, 1994-1997. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January 1999 [abstract 470].
27. 27. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen IR. Prevalence of HIV infection in the United States, 1984-1992. JAMA 1996, 276:126-131.
28. 28. Sweeney PA, Fleming PL, Karon JM, Ward JW. A minimum estimate of the number of living HIV infected persons confidentially tested in the United States. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September 1997 [abstract 1-16].
29. 29. Sorvillo F, Kerndt P, Bunch G, Odem ST, Early HIV detection: successes and failures. 12th World AIDS Conference. Geneva, July 1998 [abstract 43104].
30. 30. Centers for Disease Control. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997, 46:165-173.
31. 31. Hamers FF, Downs A, Alix J, Brunet JB. AIDS trends in Europe: decrease in west, increase in the east. Eurosurveillance 1997, 2:36-37.
32. 32. Centers for Disease Control. Update trends in AIDS incidence - United States, 1996. MMWR 1997, 46:861-867.
33. 33. Brown SS. Drawing women into prenatal care. Fam Plann Perspect 1989, 21:73-80.
34. 34. Solomon L, Moore J, Gleghorn A, Astemborski J, Vlahov D. HIV testing behaviors in a population of inner-city women at high risk for HIV infection. J Acquired Immune Defic Syndr 1996, 13:267-272.
35. 35. Ungaro AB, Luppi CG, Buccheri V, Sabino E, Eluf-Neto J. CD4+ T lymphocyte counts of HIV infected women seeking an anonymous counseling/testing service in Sao Paulo, Brazil. 12th World AIDS Conference. Geneva, July 1998 [abstract 33275]
36. 36. Miller KS, Hennessy M, Wendell DA, Webber MP, Schoenbaum EE. Behavioral risks for HIV infection associated with HIV-testing decisions. AIDS Educ Prev 1996, 8:394-402.
37. 37. Battle RS, Cummings GL, Yamada KA, Krasnovsky FM. HIV testing among low-income African American mothers. AIDS Educ Prev 1996, 8:165-175.
38. 38. Heckman TG, Sikkema KJ, Kelly JA, et al. Predictors of condom use and human immunodeficiency virus test seeking among women living in inner-city public housing developments. Sex Transm Dis 1996, 23:357-365.
39. 39. Centers for Disease Control. HIV testing among women aged 18-44 years - United States, 1991 and 1993. MMWR 1996, 45:733-737.
40. 40. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquired Immune Defic Syndr 1998, 17:253-261.
41. 41. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV infected adults in the United States. JAMA 1999, 281:2305-2315.
42. 42. Rosenberg PS, Biggar RJ, Coedert JJ. Declining age at HIV infection in the United States. N Engl J Med 1994, 330:789.
43. 43. Rotheram-Borus MJ. HIV prevention challenges - realistic strategies and early detection programs. Am J Public Health 1997, 87:544-546.
44. 44. Rotheram-Borus MJ, Murphy DA, Coleman CL, et al. Risk acts, health care, and medical adherence among HIV+ youths in care over time. AIDS Behav 1997, 1:43-52.
45. 45. Hein K, Dell R, Futterman D, Rotheram-Borus MJ, Shaffer N. Comparison of HIV+ and HIV-adolescents: risk factors and psychosocial determinants. Pediatrics 1995, 95:96-104.
46. 46. Main DS, Iverson DC, McGloin J. Comparison of HIV risk behaviors and demographics of adolescents tested or not tested for HIV infection. Public Health Rep 1994, 109:699-702.
47. 47. Pugatch D, Ramratnam M, Feller A, Price D, Thomas M, Dickinson B, Rich JD. HIV related risk factors and HIV testing levels among adolescents with drug abuse. 12th World AIDS Conference. Geneva, July 1998 [abstract 60572]
48. 48. Valdiserri RO, Moore M, Gerber AR, Campbell CH, Dillon BA, West GR. A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993, 108:12-18.
49. 49. Hegbodu AE, Frank ML, Poindexter AN, Johnson D. Characteristics of teens tested for HIV in a metropolitan area. J Adolesc Health 1994, 15:479-484.
50. 50. Phillips KA. Factors associated with voluntary HIV testing for African-Americans and Hispanics. AIDS Educ Prev 1993, 5:95-103.
51. 51. Holtzman D, Rubinson R, Bland SD, McQueen DV. HIV testing behavior and associated characteristics among US adults, 1993-1994. AIDS Behav 1998, 2:269-281.
52. 52. Porter K, Wall PG, Evans BG. Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. BMJ 1993, 307:20-23.
53. 53. Grinstead OA, Peterson JL, Faigeles B, Catania JA. Antibody testing and condom use among heterosexual African Americans at risk for HIV infection: the National AIDS Behavioral Surveys. Am J Public Health 1997, 87:857-859.
54. 54. Simon PA, Weber M, Ford WL, Cheng F, Kerndt PR. Reasons for HIV antibody test refusal in a heterosexual sexually transmitted disease clinic population. AIDS 1996, 10:1549-1553.
55. 55. Schwarcz SK, Spitters C, Ginsberg MM, Anderson L, Kellogg T, Katz MH. Predictors of human immunodeficiency virus counseling and testing among sexually transmitted disease clinic patients. Sex Transm Dis 1997, 24:347-352.
56. 56. Wiley DJ, Frerichs RR, Ford WL, Simon PA. Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted disease clinics. Sex Transm Dis 1998, 25:342-345.
57. 57. Fichtner, RR, Wolitski RJ, Johnson WD, Rabins CB, Fishbein M. Influence of perceived and assessed risk on STD clinic clients' acceptance of HIV testing, return for test results, and HIV serostatus. Psychol Health Med 1996, 1:83-98.
58. 58. Lindan CP, Avins AL, Woods WJ, Hudes ES, Clark W, Hulley S. Levels of HIV testing and low validity of self-reported test results among alcoholics and drug users. AIDS 1994, 8:1149-1155.
59. 59. Sy FS, Chng CL, Choi ST, Wong FY. Epidemiology of HIV and AIDS among Asian and Pacific Islander Americans. AIDS Educ Prev 1998, 10:4-18.
60. 60. Schwarcz SK, Katz MH, Hirozawa A, Gurley J, Lemp G. Prevention of Pneumocystis carinii pneumonia: who are we missing. AIDS 1997, 11:1263-1268.
61. 61. Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994, 344:1120-1124.
62. 62. Irwin, K, Valdiserri RO, Holmberg SD. The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS 1996, 10:1707-1717.
63. 63. Lehman JS, Hecht FM, Fleming PL, Coleman S, Chesney M, Bindman A, Osmond D. HIV testing behavior among at-risk populations: why do persons seek, defer, or avoid getting tested in the United States? 12th World AIDS Conference. Geneva, July 1998 [abstract 43103].
64. 64. Lyter DW, Valdiserri RO, Kingsley LA, Amoroso WP, Rinaldo CR. The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep 1987, 102:468-474.
65. 65. Killewo TZJ, Kwesigabo G, Comoro C, et al. Acceptability of voluntary HIV testing with counseling in a rural village in Kagera, Tanzania. AIDS Care 1998, 10:431-439.
66. 66. Sy F, Smith D, Thompson S, Jackson K. The association of perceived risk for HIV infection and self-reports of HIV antibody testing in a predominantly rural US southern state. 12th World AIDS Conference. Geneva, July 1998 [abstract 43118].
67. 67. Phillips KA, Paul J, Kegeles S, Stall R, Hoff C, Coates TJ. Predictors of repeat HIV testing among gay and bisexual men. AIDS 1995, 9:769-775.
68. 68. Norton J, Elford J, Sherr L, Miller R, Johnson MA. Repeat HIV testers at a London same-day testing clinic. AIDS 1997, 11:731-781.
69. 69. Stall R, Hoff C, Coates IJ, Paul J, Phillips KA, Ekstrand M, et al. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquired Immune Defic Syndr 1996, 11:151-160.
70. 70. Myers T, Orr KW, Locker D, Jackson EA. Factors affecting gay and bisexual men's decisions and intentions to seek HIV testing. Am J Public Health 1993, 83:701-704.
71. 71. Billington A, Imrie JC, McOwan AG, Paragreen SJ, Rogers C, French LA. Young gay men attending a dedicated service are less likely to test for HIV than peers using routine clinic services: why? 12th World AIDS Conference. Geneva, July 1998 [abstract 43130].
72. 72. Godin G, Myers T, Lambert J, Calzavara L, Locker D. Understanding the intention of gay and bisexual men to take the HIV antibody test. AIDS Educ Prev 1997, 9:31-41.
73. 73. Myers T, Godin G, Lambert J, Calzavara L, Locker D. Sexual risk and HIV-testing behaviour by gay and bisexual men in Canada. AIDS Care 1996, 8:297-309.
74. 74. Rebchook G, Hays RB, Kegeles SB. Gay community integration predicts HIV testing among US young gay men. 12th World AIDS Conference. Geneva, July 1998 [abstract 14189].
75. 75. Hickson F, Reid DS, Henderson LA, Weatherburn P, Keogh G. Treatment advances, risk taking and HIV testing history among gay men in the UK. 12th World AIDS Conference. Geneva, July 1998 [abstract 14159].
76. 76. Davis WR, Deren S, Beardsley M, Wenston J, Tortu S. Gender differences and other factors associated with HIV testing in a national sample of active drug injectors. AIDS Educ Prev 1997, 9:342-358.
77. 77. Reardon J, Warren N, Keilch R, Jenssen D, Wise F, Brunner W. Are HIV-infected drug users taking HIV tests? Am J Public Health 1993, 83:1414-1417.
78. 78. Donoghoe MC, Rhodes TJ, Hunter GM, Stimson GV. HIV testing and unreported HIV positivity among injecting drug users in London. AIDS 1993, 7:1105-1111.
79. 79. Valdiserri RO, Jones TS, West GR, Campbell CH, Thompson PI. Where injecting drug users receive HIV counseling and testing. Public Health Rep 1993, 108:294-298.
80. 80. Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health 1991, 81:1285-1290.
81. 81. Ladner J, Leroy V, Msellati P, et al. A cohort study of factors associated with failure to return for HIV post-test counseling in pregnant women: Kigali, Rwanda, 1992-1993. AIDS 1996, 10:695-675.
82. 82. Lao G, Kassler WJ, Branson BM, Peterman TA, Cohen RA. Rates of receiving the result of an HIV test: data from the US National Health Interview Survey. 12th World AIDS Conference. Geneva, July 1998 [abstract 60354].
83. 83. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. On-site, rapid HIV testing with same-day results and counseling. AIDS 1997, 11:1045-1051.
84. 84. McKenna SL, Muyinda GK, Roth D, et al. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS 1997, 11 (Suppl. 1): S103-S110.
85. 85. Phillips K, Branson B, Fernyak S, Bayer R, Chang S, Morin S. The use of home collection HIV tests in the US: barriers and solutions. 12th World AIDS Conference. Geneva, July 1998 [abstract 43133].
86. 86. Fernyak S, Phillips K, Branson B, Catania J. Home collection HIV tests in the US: those who intended to use are not using. 12th World AIDS Conference. Geneva, July 1998 [abstract 43116].
87. 87. Gallo D, George JR, Fitchen JH, et al. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. JAMA 1997, 277:254-258.
88. 88. Sy FS, Rhodes SD, Choi ST, Drociuk D, Laurent AA, Naccash RM, Kettinger LD. The acceptability of oral fluid testing for HIV antibodies: a pilot study in gay bars in a predominantly rural state. Sex Transm Dis 1998, 25:211-215.
89. 89. Behets FM, Edidi B, Quinn TC, et al. Detection of salivary HIV-1-specific IgG antibodies in high-risk populations in Zaire. J Acquired Immune Defic Syndr 1991, 4:183-187.
90. 90. Gerbert B, Maguire BT, Coates TJ. Are patients talking to their physicians about AIDS? Am J Public Health 1990, 80:467-468.
91. 91. Boekeloo BO, Marx ES, Kral AH, Coughlin SC, Bowman J, Rabin DL. Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health 1991, 81:1645-1648.
92. 92. Kerr SH, Valdiserri RO, Loft J, et al. Primary care physicians and their HIV prevention practices. AIDS Patient Care 1996, 10:227-235.
93. 93. Haas DM, Coe RM. Do physicians discuss HIV and AIDS with patients? A survey of physician practices. J Community Health 1997, 6:401-416.
94. 94. Ethier K, Fox-Tierney RA, Ickovics JR. Prenatal HIV counseling and testing: rates and determinants among women at public health clinics. 12th World AIDS Conference. Geneva, July 1998 [abstract 43111].
95. 95. Royce R, Walter E, Fernandez I, Minkoff H, Ickovics J, Simonds RJ. HIV counseling and testing among parturients sampled at four US sites. 12th World AIDS Conference. Geneva, July 1998 [abstract 43117].
96. 96. Fernandez MI, Wilson T, Moore J, Ethier K, Walter E. Acceptance of HIV testing among women in prenatal care in Miami, New York City, and Connecticut. 12th World AIDS Conference. Geneva, July 1998 [abstract 43142].
97. 97. Kissinger P, Fuchs N, Herwehe J, Groft C, Gruber D. Fear, low risk perception and lack of knowledge remains a barrier to HIV testing among high risk pregnant women in New Orleans, LA. 12th World AIDS Conference. Geneva, July 1998 [abstract 23298].
98. 98. Bernhardt S, Campbell T. Reasons for declining HIV testing in a British antenatal setting. 12th World AIDS Conference. Geneva, July 1998 [abstract 23472].
99. 99. Meadows J, Catalan J. Why do antenatal attenders decide to have the HIV antibody test? Int J STD AIDS 1994, 5:400-404.
100. 100. Kalichman SC, Kelly JA, Hunter TL, Murphy DA, Tyler R. Culturally tailored HIV-AIDS risk reduction messages targeted to African-American urban women: impact on risk sensitization and risk reduction. J Consult Clin Psychol 1993, 61:291-295.
101. 101. Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994, 330:763-768.
102. 102. Henry J Kaiser Family Foundation and Michaels Opinion Research. Hearing their voices: a qualitative research study on HIV testing in higher risk teens. Menlo Park, CA: June 1999.
103. 103. Hudson MMT, Nelson WL, Ronalds CJ, Anderson J, Jeffries DJ. HIV antibody testing: genito-urinary clinic or additional site same-day testing service. AIDS Care 1997, 9:209-215.
104. 104. Hirano D, Gellert GA, Fleming K, Boyd D, Englender SJ, Hawks H. Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health 1994, 84:2008-2010.
105. 105. Fehrs LJ, Foster LR, Fox V, Fleming D, McAlister RO, Modesitt S, Conrad R. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet 1988, ii:379-381.
106. 106. Kegeles SM, Catania JA, Coates TH, Pollack LM, Lo B. Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances. AIDS 1990, 4:585-588.
107. 107. Phillips KA, Coates TJ, Eversley RB, Catania JA. Who plans to be tested for HIV or would get tested if no one could find out the results? Am J Prev Med 1995, 11:156-162.
108. 108. Meyer PA, Jones JL, Garrison CZ, Dowda H. Comparison of individuals receiving anonymous and confidential testing for HIV. South Med J 1994, 87:344-347.
109. 109. Kassler WJ, Meriwether RA, Klimko TB, Peterman TA, Zaidi A. Eliminating access to anonymous HIV antibody testing in North Carolina: effects on HIV testing and partner notification. J Acquired Immune Defic Syndr 1997, 14:281-289.
110. 110. Picciotto-Hertz I, Lee LW, Hoyo C. HIV test-seeking before and after the restriction of anonymous testing in North Carolina. Am J Public Health 1996, 86:1446-1450.
111. 111. Bindman AB, Osmond D, Hecht FM, et al. Multistate evaluation of anonymous HIV testing and access to medical care. JAMA 1998, 280:1416-1420.
112. 112. Woods W, McFarland W, Sabatino J, Rinaldi J, Adler B, Lihatsh I, Dilley J. Names reporting of HIV-positives would reduce HIV testing among men who have high-risk sex with men in San Francisco, CA. 12th World AIDS Conference. Geneva, July 1998 [abstract 60386].
113. 113. Kegeles SM, Coates TL, Lo B, Catania JA. Mandatory reporting of HIV testing would deter men from being tested. JAMA 1989, 261:1275-1276.
114. 114. Fordyce EJ, Sambula S, Stoneburner R. Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested. JAMA 1989, 262:349.
115. 115. Hirano D, England B, Hoff C, et al. Reporting HIV infections. J Acquired Immune Defic Syndr 1994, 7:417-418.
116. 116. Nakashima AK, Horsley R, Frey RL, Sweeney PA, Weber JT, Fleming PL. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs. JAMA 1998, 280:1421-1426.
117. 117. Centers for Disease Control and Prevention. HIV testing among populations at risk for HIV infection - nine states, November 1995-December 1996. MMWR 1998, 47:1086-1091.
118. 118. Manfredi C, Lacey L, Warneck R. Results of an intervention to improve compliance with referrals for evaluation of suspected malignancies at neighborhood public health centers. Am J Public Health 1990, 80:85-87.
119. 119. Advisory Committee on the Prevention of HIV Infection. External review of CDC's HIV prevention strategies. Atlanta, GA: June 1994.
120. 120. Kilmarx PH, Hamers FF, Peterman TA. Living with HIV: experiences and perspectives of HIV-infected sexually transmitted disease clinic patients after posttest counseling. Sex Transm Dis 1998, 25:28-37.
121. 121. Schwartz B, Dilley J, Sorensen JL. Case management of substance abusers with HIV disease. J Case Manage 1994, 3:173-178.
122. 122. Scott DE, Hu DJ, Hanson IC, Fleming PL, Northup T. Case management of HIV-infected children in Missouri. Public Health Rep 1995, 110:355-356.
123. 123. O'Connor CO, Taveira P, Patsdaughter CA, Grindel CG. A circle of care: beyond HIV counseling and testing. 12tn World AIDS Conference. Geneva, July 1998 [abstract 60636].
124. 124. Valdiserri RO, Robinson C, Lin LS, West GR, Holtgrave DR. Determining allocations for HIV prevention interventions: assessing a change in federal funding policy. AIDS Public Policy 1997, 12:138-148.
125. 125. Danziger R. HIV testing for HIV prevention: a comparative analysis of policies in Britain, Hungary, and Sweden. AIDS Care 1998, 10:563-570.
126. 126. Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS. One world, one hope: the cost of providing antiretroviral therapy to all nations. AIDS 1998, 12:2203-2209.
127. 127. Campbell CH, Marum ME, Alwano-Edyegu MG, Dillon BA, Moore M, Gumisiriza E. The role of HIV counseling and testing in the developing world. AIDS Educ Prev 1997, 9 (Suppl. B):92-104.
128. 128. Bozzette SA, Berry SH, Duan N, et al. The care of HIV infected adults in the United States. N Engl J Med 1998, 339:1897-1904.
129. 129. Lamptey PR, Price JE. Social marketing sexually transmitted disease and HIV prevention: a consumer-centered approach to achieving behaviour change. AIDS 1998, 12:S1-S9.
130. 130. Futterman D, Jean-Louis S, Hoffman ND, Chabon B. Promoting HIV counseling and testing to adolescents: contributions of social marketing. 12th World AIDS Conference. Geneva, July 1998 [abstract 33434].
131. 131. Walsh DC, Rudd RE, Moeykens BA, Moloney TW. Social marketing for public health. Health Affairs 1993, 12:104-119.
132. 132. Dearing JW, Rogers EM, Meyer G, Casey MK, Rao N, Campo S, Henderson GM. Social marketing and diffusion-based strategies for communicating with unique populations: HIV prevention in San Francisco. J Health Commun 1996, 1:343-363.
133. 133. Ross JD, Scott GR. The association between HIV media campaigns and number of patients coming forward for HIV antibody testing. Genitourin Med 1993, 69:193-195.
134. 134. Griffith R, Mandalia S, Beck EJ, Kenny C, Watkins RP, Claydon E, Harris JR. HIV media campaigns and HIV-1 testing trends at a London genitourinary medicine clinic, 1985-1993. AIDS 1995, 9:1367-1372.
135. 135. Holman CD, Bucens MR, Sesnan TM. AIDS and the grim reaper campaign. Med J Aust 1987, 147:306.
136. 136. Centers for Disease Control. HIV-infection prevention messages for injecting drug users: sources of information and the use of mass media - Baltimore, 1989. MMWR 1991, 40:465-469.
137. 137. Centers for Disease Control. Technical guidance on HIV counseling. MMWR 1993, 42 (RR-2): 8-17.
138. 138. Rollnick S, Kinnersley P, Stott N. Methods of helping patients with behaviour change. BMJ 1993, 307:188-190.
139. 139. Pergami A, Catalan J, Hulme N, Burgess A, Gazzard B. How should a positive HIV result be given? The patient's view. AIDS Care 1994, 6:21-27.
140. 140. Lefebvre RC, Flora JA. Social marketing and public health intervention. Health Educ Quart 1988, 15:299-315.
141. 141. Sweat M, Balmer D, Sangiwa G. Cost to clients and willingness to pay for HIV counseling and testing in Kenya and Tanzania: results from the Voluntary HIV Counseling and Testing Study. 12th World AIDS Conference. Geneva, July 1998 [abstract 24135].
142. 142. Danzinger R. Discrimination against people with HIV and AIDS in Poland. BMJ 1994, 308:1145-1147.
143. 143. Gostin LO. The AIDS litigation project: a national review of court and human rights commission decisions. JAMA 1990, 263:2086-2093.
144. 144. Neilsen GA, Young FJ. HIV/AIDS, advocacy and anti-discrimination legislation - the Australian response. Int J STD AIDS 1994, 5:13-17.
145. 145. Swiss Federal Office of Public Health. HIV and AIDS: national program, 1999-2003. Bern, Switzerland: 1999.
146. 146. Institute of Medicine. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press; 1998.
147. 147. Perlman JL, Perlman J, Tellez MS, et al. Hospital-based CTRPN: uncoupling diagnostic testing from prevention counseling at San Francisco General Hospital. 12th World AIDS Conference. Geneva, July 1998 [abstract 60557].
148. 148. Mosen DM, Wenger NS, Shapiro MF, Andersen RM, Cunningham WR. Is access to medical care associated with receipt of HIV testing and counseling? AIDS Care 1998, 10:617-628.
149. 149. Alexander L, Sattah M, Ziemer DB, Del Rio C. Missed opportunities for HIV diagnosis at an inner city hospital in the United States. 12th World AIDS Conference. Geneva, July 1998 [abstract 43131].
150. 150. Office of National AIDS Policy. Youth & HIV/AIDS: an American agenda. Washington, DC: 1996.
151. 151. Institute of Medicine. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press; 1997.
152. 152. Soriana S, Cahn R, Weller S, Bloch C, Cahn P. Perception of risk and delay for HIV testing. 12th World AIDS Conference. Geneva, July 1998 [abstract 24316].
153. 153. Demas P, Schoenbaum EE, Hirky AF, Wills TA, Doll LS, Hartel DM, Klein RS. The relationship of HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS Behav 1998, 2:283-292.
154. 154. Rotheram-Borus MJ, Miller S. Secondary prevention for youths living with HIV. AIDS Care 1998, 10:17-34.
155. 155. Ryan B. Outreach to gay, lesbian, and bisexual youth: a Canadian experience. 2nd International Symposium on HIV Prevention. Geneva, June 1998 [unnumbered abstract].